195 related articles for article (PubMed ID: 26632727)
1. Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer.
Meng X; Huang Z; Di J; Mu D; Wang Y; Zhao X; Zhao H; Zhu W; Li X; Kong L; Xing L
Medicine (Baltimore); 2015 Nov; 94(47):e2106. PubMed ID: 26632727
[TBL] [Abstract][Full Text] [Related]
2. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
4. Frequency of HER-2 positivity in rectal cancer and prognosis.
Conradi LC; Styczen H; Sprenger T; Wolff HA; Rödel C; Nietert M; Homayounfar K; Gaedcke J; Kitz J; Talaulicar R; Becker H; Ghadimi M; Middel P; Beissbarth T; Rüschoff J; Liersch T
Am J Surg Pathol; 2013 Apr; 37(4):522-31. PubMed ID: 23282976
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab.
Wang X; Cai L; Ye F; Li M; Ma L; Geng C; Song Z; Liu Y
Medicine (Baltimore); 2019 Sep; 98(36):e16937. PubMed ID: 31490377
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: association with response to neoadjuvant therapy and prognosis.
Meng X; Wang R; Huang Z; Zhang J; Feng R; Xu X; Zhu K; Dou X; Chen D; Yu J
Cancer Sci; 2014 Jul; 105(7):818-24. PubMed ID: 24730770
[TBL] [Abstract][Full Text] [Related]
7. The total number of lymph nodes harvested from pathological T3N0 rectal cancer patients: Prognostic significance and potential indication for postoperative radiotherapy.
Xiao WW; Zhang LN; You KY; Huang R; Yu X; Chang H; Ding PR; Gao YH
J Cancer Res Ther; 2018 Jun; 14(Supplement):S288-S294. PubMed ID: 29970678
[TBL] [Abstract][Full Text] [Related]
8. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular and neural invasion in low-lying rectal carcinoma.
Moreira LF; Kenmotsu M; Gochi A; Tanaka N; Orita K
Cancer Detect Prev; 1999; 23(2):123-8. PubMed ID: 10101593
[TBL] [Abstract][Full Text] [Related]
10. A scoring system to predict inferior mesenteric artery lymph node metastasis and prognostic value of its involvement in rectal cancer.
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW
Int J Colorectal Dis; 2014 Mar; 29(3):293-300. PubMed ID: 24337892
[TBL] [Abstract][Full Text] [Related]
11. The predicting value of postoperative body temperature on long-term survival in patients with rectal cancer.
Yu H; Luo Y; Peng H; Kang L; Huang M; Luo S; Chen W; Yang Z; Wang J
Tumour Biol; 2015 Sep; 36(10):8055-63. PubMed ID: 25976505
[TBL] [Abstract][Full Text] [Related]
12. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
[TBL] [Abstract][Full Text] [Related]
13. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
Seddik Y; Brahmi SA; Afqir S
Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
[TBL] [Abstract][Full Text] [Related]
14. HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer.
Kwon MJ; Soh JS; Lim SW; Kang HS; Lim H
Pathol Res Pract; 2019 May; 215(5):910-917. PubMed ID: 30772061
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.
Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
Jung W; Kim K; Kim J; Shim SJ
In Vivo; 2020; 34(3):1247-1253. PubMed ID: 32354915
[TBL] [Abstract][Full Text] [Related]
17. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer.
Koca D; Binicier C; Oztop I; Yavuzsen T; Ellidokuz H; Yilmaz U
J BUON; 2012; 17(2):291-8. PubMed ID: 22740208
[TBL] [Abstract][Full Text] [Related]
19. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
20. A Distal Resection Margin of ≤1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery: The Role of a Positive Distal Margin in Rectal Cancer Surgery.
Zeng WG; Liu MJ; Zhou ZX; Wang ZJ
Dis Colon Rectum; 2017 Nov; 60(11):1175-1183. PubMed ID: 28991082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
